Drug Type Small molecule drug |
Synonyms (−)-scopolamine methobromide, (−)-scopolamine methyl bromide, Hyoscine methobromide + [13] |
Target |
Action antagonists |
Mechanism mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1994), |
Regulation- |
Molecular FormulaC18H24BrNO4 |
InChIKeyCXYRUNPLKGGUJF-RAFJPFSSSA-M |
CAS Registry155-41-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D00715 | Methscopolamine Bromide |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Motion Sickness | China | 01 Jan 1994 | |
| Nausea | China | 01 Jan 1994 | |
| Peptic Ulcer | China | 01 Jan 1994 |





